Clinical and biochemical parameters of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its methyl-phenyl and methoxy-phenyl derivatives in C57B1/6 mice
โ Scribed by N. I. Lermontova; L. S. Solyakov; S. O. Bachurin; T. P. Serkova; L. N. Petrova; O. A. Dranyi; S. E. Tkachenko; V. V. Kalashnikov
- Publisher
- Springer US
- Year
- 1990
- Tongue
- English
- Weight
- 376 KB
- Volume
- 110
- Category
- Article
- ISSN
- 0007-4888
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The present study examines the motor responses of 10-to 12-month-old, male C57 mice that were either given intraperitoneal (IP) injections of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; 30 mg/kg per day) or vehicle for 10 consecutive days, followed by IP injections of levodopa (200 mg/kg) pl
Previous studies have suggested a role for the retrograde messenger, nitric oxide (NO), in methamphetamine (METH)-and 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Since evidence supported the involvement of the neuronal nitric oxide synthase (nNOS) isoform i
## Abstract Monoamine oxidase B metabolizes 1โmethylโ4โphenylโ1,2,3,6โtetrahydropyridine (MPTP; **1**) first to 1โmethylโ4โphenylโ2,3โdihydropyridinium salt (MPDP^+^; **5**), and then to 1โmethylโ4โphenylphridinium salt (MPP^+^; **7**). Chemical synthesis of MPDP^+^ and its 5โmethyl analog **6** wa